InspireMD, developer of the CGuard® Prime carotid stent system, appoints Dan Dearen to its Board of Directors.
Mr. Dearen brings 40 years of leadership experience in the medical device and life sciences sectors.
His appointment aligns with InspireMD's mission to lead the carotid intervention market and create long-term value.
Extensive Experience
Dan Dearen has a proven track record of guiding MedTech companies through critical financial milestones.
Strategic Insight
His strategic insight will support InspireMD in advancing its position in the market.
Potential Impact
With FDA approval for CGuard Prime, InspireMD aims to change the standard of care in vascular medicine.
- Mr. Dearen's appointment brings valuable expertise to the board, enhancing InspireMD's leadership.
- His experience in guiding companies through financial milestones positions InspireMD for growth and value creation.
The appointment of Dan Dearen to InspireMD's Board of Directors signifies a pivotal moment for the company, with the potential to drive significant growth and innovation in the medical device sector.